Roderick Wong - Profile and Investment Details

Investor Profile

Roderick Wong is a Hedge Fund, Venture Capital, Investor based in New York City, New York, United States with a diverse investment portfolio that includes companies such as AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies, Orchestra BioMed, Encoded Therapeutics, Beta Bionics, ARMO BioSciences, Athira Pharma, immatics biotechnologies, Orchard Therapeutics, UNUM Therapeutics, Avidity Biosciences, Landos Biopharma, Pulmonx, Attune PharmaceuticalsNuance Biotech, Stoke Therapeutics, Ventyx Biosciences, Prometheus Biosciences, Tenaya Therapeutics, NiKang Therapeutics, Immunocore, Solid Biosciences, Milestone Pharmaceuticals, Biomea Fusion, Visus Therapeutics, Artiva Biotherapeutics, UroGen Pharma, ITeos Therapeutics, C4 Therapeutics, Pyxis Oncology, Jixing Pharmaceuticals, . Over time, Roderick Wong has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Roderick Wong is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Investment Management, Life Science, Biotechnology, Electronic Health Records (EHR), Genomics, Health and Hospital Services, Clinical Trials, FinTech, Health Diagnostics, Digital Health, Medical, Therapeutics, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Roderick Wong, as their portfolio suggests a familiarity and interest in this area.

Understanding Roderick Wong’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.